Protalix Biotherapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Protalix Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protalix Biotherapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protalix Biotherapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $389k | 175k | 2.22 |
| 2025-06-30 | $259k | 175k | 1.48 |
| 2024-03-31 | $194k | 154k | 1.26 |
| 2023-12-31 | $273k | 154k | 1.78 |
| 2023-09-30 | $255k | 154k | 1.66 |
| 2023-06-30 | $257k | 128k | 2.00 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management